{
  "slug": "allelica",
  "name": "Allelica",
  "description": "Allelica provides state-of-the-art multi-ancestry polygenic risk scores (PRS) and bioinformatics solutions that integrate genetics into clinical practice. Their platform helps physicians identify high-risk patients for common diseases like cardiovascular disease and breast cancer, optimize clinical trials for pharmaceutical companies, and empower clinical laboratories to offer advanced genomic testing.",
  "url": "https://optimly.ai/brand/allelica",
  "websiteUrl": "https://allelica.com/",
  "logoUrl": "https://logo.clearbit.com/allelica.com",
  "baiScore": 51.7,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Genomic and Multi-Omics Sequencing and Analysis Services",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-18T14:59:21.387Z",
  "verifiedVitals": {
    "website": "https://allelica.com",
    "category": "Biotechnology",
    "what_it_does": "Allelica provides advanced polygenic risk score (PRS) technology and bioinformatics solutions to integrate genetics into clinical practice, identify high-risk patients for common diseases, and optimize clinical trials. They offer tools for physicians, secure bioinformatics platforms for laboratories, and trial stratification services for pharmaceutical and biotech companies.",
    "primary_audience": "Physicians, clinical laboratories, pharmaceutical and biotech companies",
    "core_product": "Polygenic Risk Scores (PRS) and related platforms/tests such as Allelica AbsoluteDx™ and Breast Risk Reveal™",
    "pricing_model": null,
    "parent_ownership": null,
    "named_competitors": null
  },
  "intentTags": {
    "problemIntents": [
      "Inadequacy of standard clinical tools for identifying inherited disease risk.",
      "Difficulty in risk stratification for patients with 'normal' conventional markers.",
      "Lack of personalized, evidence-based interventions in traditional care.",
      "Inefficiencies and high costs in clinical trial design and execution.",
      "Challenges for clinical laboratories in implementing advanced genomic testing in-house.",
      "Need for comprehensive, multi-ancestry genetic risk assessment."
    ],
    "solutionIntents": [
      "Integrating polygenic risk scores (PRS) into clinical practice.",
      "Providing multi-ancestry validated PRS for diverse populations.",
      "Enhancing traditional risk assessments with genomic insights.",
      "Enabling early identification of high-risk patients for preventive care.",
      "Supporting confident clinical decision-making.",
      "Offering secure and scalable bioinformatics solutions for labs.",
      "Optimizing clinical trials through precision patient stratification.",
      "Reducing clinical trial timelines and costs."
    ],
    "evaluationIntents": [
      "Clinical utility and validity of polygenic risk scores.",
      "Ancestry diversity and calibration of genetic tests.",
      "Integration capabilities with existing clinical and lab workflows.",
      "Compliance with healthcare regulations (CLIA, HIPAA, GDPR).",
      "Impact on patient outcomes and preventive care.",
      "Evidence supporting PRS in guidelines (e.g., ACC/AHA).",
      "Scalability and customization of genomic platforms."
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789846594721
}